...
首页> 外文期刊>Therapeutic advances in musculoskeletal disease. >Autologous costal chondral transplantation and costa-derived chondrocyte implantation: emerging surgical techniques
【24h】

Autologous costal chondral transplantation and costa-derived chondrocyte implantation: emerging surgical techniques

机译:自体肋骨骨性移植和Costa衍生的软骨细胞植入:新兴手术技术

获取原文
   

获取外文期刊封面封底 >>

       

摘要

It is a great challenge to cure symptomatic lesions and considerable defects of hyaline cartilage due to its complex structure and poor self-repair capacity. If left untreated, unmatured degeneration will cause significant complications. Surgical intervention to repair cartilage may prevent progressive joint degeneration. A series of surgical techniques, including biological augmentation, microfracture and bone marrow stimulation, autologous chondrocyte implantation (ACI), and allogenic and autogenic chondral/osteochondral transplantation, have been used for various indications. However, the limited repairing capacity and the potential pitfalls of these techniques cannot be ignored. Increasing evidence has shown promising outcomes from ACI and cartilage transplantation. Nevertheless, the morbidity of autologous donor sites and limited resource of allogeneic bone have considerably restricted the wide application of these surgical techniques. Costal cartilage, which preserves permanent chondrocytes and the natural osteochondral junction, is an ideal candidate for the restoration of cartilage defects. Several in vitro and in vivo studies have shown good performance of costal cartilage transplantation. Although costal cartilage is a classic donor in plastic and cosmetic surgery, it is rarely used in skeletal cartilage restoration. In this review, we introduce the fundamental properties of costal cartilage and summarize costa-derived chondrocyte implantation and costal chondral/osteochondral transplantation. We will also discuss the pitfalls and pearls of costal cartilage transplantation. Costal chondral/osteochondral transplantation and costa-based chondrocytotherapy might be up-and-coming surgical techniques for recalcitrant cartilage lesions.
机译:由于其复杂的结构和差的自我修复能力,治疗症状性病变和透明软骨相当大的缺陷是一个巨大的挑战。如果留下未经处理的,那不清楚的退化会导致显着的并发症。手术干预修复软骨可能预防进步的关节变性。一系列手术技术,包括生物增强,微折衷和骨髓刺激,自体软骨细胞植入(ACI)和同种异体和容易性骨髓/骨质移植,已用于各种适应症。然而,无法忽视有限的修复能力和这些技术的潜在陷阱。越来越多的证据表明了ACI和软骨移植的有希望的结果。然而,自体供体部位的发病率和同种异体骨的有限资源有很大限制了这些手术技术的广泛应用。肋骨软骨,保留永久性软骨细胞和天然骨质色神经连接,是恢复软骨缺陷的理想候选者。几种体外和体内研究表明昂贵软骨移植的良好表现。虽然肋骨软骨是塑料和化妆品手术的经典捐赠者,但它很少用于骨骼软骨恢复。在这篇综述中,我们介绍了肋骨软骨的基本性质,并概述了Costa衍生的软骨细胞植入和肋骨骨髓/骨质细胞移植。我们还将讨论肋骨包裹移植的陷阱和珍珠。基于肋骨软骨病变的肋骨骨髓/骨髓移植和肋骨骨髓间移植和肋骨细胞疗法可能是即将到来的外科手术技巧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号